Applied Biosystems today reported that its second-quarter revenues increased 4 percent year over year to $482 million, but excluding the impact of foreign currency, sales growth would have been 6 percent for the quarter.

DNA sequencing revenues fell 1 percent to $140.7 million year over year, and the firm is predicting a continued decline in sales of those products over the rest of the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.